Pharmacogenomics of Heparin-Induced Thrombocytopenia (PHIT)
Sponsor: American College of Clinical Pharmacy
Listed as NCT02717039, this observational or N/A phase trial focuses on Heparin-induced Thrombocytopenia and remains actively recruiting participants. Sponsored by American College of Clinical Pharmacy, it has been updated 14 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
May 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — May 2023 [monthly]
Recruiting
-
May 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Apr 2020 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American College of Clinical Pharmacy
- University of Arizona
For direct contact, visit the study record on ClinicalTrials.gov .